ERElisa de Paula França Resende

Elisa de Paula França Resende

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elisa de Paula França Resende has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Colchicine for Prevention of Non-cardioembolic Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    by Guilherme Octávio Martins Bruno, Inácio Ferreira Goulart, João Vitor Sabadine Lima, Mateus Resende Pires de Souza, Thiago Santos Silveira, Sávio Batista, Karlos Daniel Araújo dos Santos, Elisa de Paula França Resende, Srinath Ramaswamy, Matheus Henrique Leite e Silva, et al.

  • Open Access

    Biological pathways related to mirna-125a-5p in behavioral variant of frontotemporal dementia

    by Jessica Diniz Pereira, Leticia Moreira Silva, Mhai Ozawa, Jéssica Abdo Gonçalves Tosatti, Stephanny Pinto Oliveira Lima, Isabela Resende Silva, Vinicius Ribeiro Jeunon, Maria das Graças Carvalho, Elisa de Paula França Resende, Leonardo Cruz de Souza, et al.

    Background: Frontotemporal dementia (FTD) comprises a group of neurodegenerative disorders that lead to progressive changes in language, behavior, personality, and movement. Accounting for approximately 60% of cases, the behavioral variant (bvFTD) represents the most common clinical presentation of FTD. MicroRNAs (miRNAs) are small non-coding RNAs involved in gene regulation and are expressed in various biological fluids. Considering bvFTD as an inflammatory disorder, this study investigated the expression of inflammation-related miRNAs in individuals with bvFTD compared with age- and sex-matched cognitively healthy controls. Methods: Twenty patients with bvFTD and 20 cognitively healthy controls, matched for age and sex, were included in the study. Serum levels of miRNA-30c-5p and miRNA-125a-5p were analyzed. Results: miRNA-125a-5p expression was upregulated in individuals with bvFTD compared with controls (fold change = 2.02). No significant differences between groups were observed for miRNA-30c-5p. An inverse correlation was identified between miRNA-125a-5p expression and age within the bvFTD group. Pathway enrichment analysis revealed that miRNA-125a-5p was significantly involved in the regulation of genes associated with insulin receptor signaling, SUMOylation, SUMO E3 ligase–mediated protein modification, SUMOylation of chromatin organization proteins, estrogen-dependent gene expression, extracellular exosome pathways, neuron migration, microtubule dynamics, and nervous system development. Conclusions: These findings suggest that miRNA-125a-5p may play an important role in FTD-related biological pathways, underscoring its potential as a molecular marker in the pathophysiology of this disorder.

  • Open Access

    Neuropsychiatric symptoms and social cognition in frontotemporal dementia and Alzheimer’s disease

    by Lucas de Andrade Saraiva, Elisa de Paula França Resende, Luciano Inácio Mariano, Danielly Silva Paula, Paulo Caramelli, João Vinícius Salgado, Leonardo Cruz de Souza

    Neuropsychiatric symptoms (NPS) are common in dementia and may hinder differential diagnosis between behavioral variant frontotemporal dementia (bvFTD) and Alzheimer’s disease (AD). Despite investigations of NPS and social cognition, particularly Theory of Mind (ToM) and emotion recognition, their precise, differential impact on social cognition in bvFTD versus AD remains less characterized. Objective: This study examined NPS in bvFTD and their association with social cognition, comparing results to AD. Methods: Patients with bvFTD (n=13) and AD (n=18) were assessed using neuropsychiatric and cognitive batteries measuring depression, anxiety, mania, and psychosis. Social cognition was evaluated with the Mini-Social and Emotional Assessment (mini-SEA), including the Faux-Pas test (ToM) and the Facial Emotion Recognition Test (FERT). Results: The groups did not differ in sex, education, or disease duration. Compared to AD, bvFTD patients had higher manic symptoms (p<0.001) and schizophrenia spectrum symptoms, particularly in negative (p<0.001) and resistance/hostility (p=0.034) symptoms. In bvFTD, depressive (p=0.020) and anxious (p=0.045) symptoms positively correlated with the Faux-Pas test, while positive psychotic symptoms correlated negatively (p=0.005). In AD, obsessive-compulsive (p=0.013) and disorganized psychotic symptoms (p=0.009) negatively correlated with the Faux-Pas test, while manic symptoms negatively correlated with the FERT (p=0.033). Conclusion: bvFTD patients displayed more schizophrenic and manic symptoms than AD, with NPS impacting social cognition differently in each condition.

  • Open Access

    Physiopathological mechanisms underlying Alzheimer’s disease: a narrative review

    by Eliasz Engelhardt, Elisa de Paula França Resende, Karina Braga Gomes

    The neuropathological signature of Alzheimer’s disease (AD) comprises mainly amyloid plaques, and neurofibrillary tangles, resulting in synaptic and neuronal loss. These pathological structures stem from amyloid dysfunctional metabolism according to the amyloid cascade hypothesis, leading to the formation of plaques, and apparently inducing the initiation of the abnormal tau pathway, with phosphorylation and aggregation of these proteins, ultimately causing the formation of tangles. In this narrative review, the existing hypothesis related to the pathophysiology of AD were compiled, and biological pathways were highlighted in order to identify the molecules that could represent biological markers of the disease, necessary to establish early diagnosis, as well as the selection of patients for therapeutical interventional strategies.


  • Open Access

    Use of anti-amyloid therapies for Alzheimer’s disease in Brazil: a position paper from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology

    by Breno José Alencar Pires Barbosa, Elisa de Paula França Resende, Raphael Machado Castilhos, Wyllians Vendramini Borelli, Norberto Anízio Ferreira Frota, Marcio Luiz Figueredo Balthazar, Augusto Celso Scarparo Amato Filho, Jerusa Smid, Maira Tonidandel Barbosa, Artur Martins Coutinho, et al.

    Novel therapies for Alzheimer’s disease, particularly anti-amyloid drugs like lecanemab and donanemab, have shown modest clinical benefits but also significant risks. The present paper highlights the challenges of access to diagnosis, cost-effectiveness, safety, and the need for more representation of diverse populations in clinical trials. Recommendations include careful patient selection, risk-benefit analysis, and the importance of proven amyloid pathology for treatment. Future work involves further research on anti-amyloid therapies in Brazil and the development of more effective treatments for Alzheimer’s disease.


  • Open Access

    Guidelines for the use and interpretation of Alzheimer’s disease biomarkers in clinical practice in Brazil: recommendations from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology

    by Adalberto Studart Neto, Breno José Alencar Pires Barbosa, Artur Martins Coutinho, Leonardo Cruz de Souza, Lucas Porcello Schilling, Mari Nilva Maia da Silva, Raphael Machado Castilhos, Paulo Henrique Ferreira Bertolucci, Wyllians Vendramini Borelli, Hélio Rodrigues Gomes, et al.

    In recent years, the diagnostic accuracy of Alzheimer’s disease has been enhanced by the development of different types of biomarkers that indicate the presence of neuropathological processes. In addition to improving patient selection for clinical trials, biomarkers can assess the effects of new treatments on pathological processes. However, there is concern about the indiscriminate and poorly supported use of biomarkers, especially in asymptomatic individuals or those with subjective cognitive decline. Difficulties interpreting these tests, high costs, and unequal access make this scenario even more challenging in healthcare. This article presents the recommendations from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology (Departamento Científico de Neurologia Cognitiva e Envelhecimento da Academia Brasileira de Neurologia) regarding the rational use and interpretation of Alzheimer’s disease biomarkers in clinical practice. The clinical diagnosis of cognitive-behavioral syndrome is recommended as the initial step to guide the request for biomarkers.


  • Open Access

    Episodic memory improvement in illiterate adults attending late-life education irrespective of low socioeconomic status: insights from the PROAME study

    by Emma Patrice Ruppert, João Victor de Faria Rocha, Aída Lourandes da Silva, Kelle Luisa dos Santos Tomaz, Clarisse Vasconcelos Friedlaender, Joanna de Castro Magalhães Assenção, Luciana Paula Rincon, Norton Gray Ferreira Ribeiro, Dulce Constantina de Souza Santos, Ana Paula Zacarias Lima, et al.

    The majority of people with dementia live in low or middle-income countries (LMICs) where resources that play a crucial role in brain health, such as quality education, are still not widely available. In Brazil, illiteracy remains a prevalent issue, especially in communities with lower socioeconomic status (SES). The PROAME study set out to explore basic education in illiterate adults as a means to improve cognitive reserve. Objective: This manuscript aims to explore the relationship between SES and learning, as well as cognitive outcomes, in an older illiterate population. Methods: This six-month clinical trial (NCT04473235) involved 108 participants, of which 77 concluded all assessments, enrolled in late-life basic education. SES assessments included Quality of Urban Living Index, Municipal Human Development Index and Household SES calculated for each participant. Cognitive assessments encompassed the Free and Cued Selective Reminding Test (FCSRT), a word list to assess reading, and the Beta III matrix. Results: The sample consisted primarily of women, with a mean age of 58.5. Participants improved their reading (p=0.01) and their FCSRT (p=0.003). Regarding episodic memory, women outperformed men (p=0.007) and younger participants improved more than their older counterparts (p=0.001). There was no association observed between SES and cognitive outcomes. Conclusion: Irrespective of SES, participants demonstrated positive outcomes after attending basic education. These findings highlight that late life education could be an important non-pharmacologic preventative measure, especially in LMICs.


  • Open Access

    the impacts of language decoding and literacy of adults in the cognition of elderly people and its occupational engagement

    by Kelle Luisa Santos Tomaz, Francisca Izabel Pereira Maciel, Elisa de Paula França Resende, Ana Paula Zacarias, Joanna Assenção, Norton Grey Ribeiro, Lea T Grinberg, Luciana Paula Rincon, Clarisse Friedlander, João Victor, et al.

    Background: Brazil has a population of 11 million illiterate individuals. This percentage among Brazilians over 60 equals 18%. In view of this, researchers from the Colleges of Medicine and Education from Federal University of Minas Gerais, Brazil, created Alfabetização e Memória (PROAME) – a project that investigates the relations of late literacy with adults’ psychosocial health. The analysis carried out associated the variables of mental and social health to the literacy process, taking into account memory and language aspects.Method: This study evaluated 130 illiterate adults living in the city of Belo Horizonte, Brazil. 108 participants fitted all criteria and agreed to undergo this survey. There were 31 men (28,4%) and 78 women (71,5%); their average age was 58,5 (±9,6). Regarding race, 91% were black/brown (83,4%), 11 were white (10,1%) and 1 was indigenous (0,1%). 80 of those participants completed all clinical evaluations, interviews and pedagogical diagnoses before and after our intervention through a period of 7 months. The goal was to qualitatively analyze the participants’ discourse, focusing on evidence of the improvement of their autonomy. This was done by associating aspects from occupational engagement to the so‐called social literacy, which consist in the practical application of reading and writing on previously illiterate adults.Result: The average age of the participants who completed the evaluations was 58,9 (±9,1), and 64 of them were women (80,0%). Both the interviews (made before and after our intervention) and the pedagogic report of 15 random individuals were analyzed. The results show progress in: their engagement in meaningful activities of daily life; their autonomy, sociability and self esteem; their use of technological applications; their occupational repertoire and their reading and writing abilities.Conclusion: A pedagogical intervention made up by specific reading and writing activities, carried out with illiterate adults during 6 months, resulted in benefits for the participants. However, in face of the high illiteracy levels in Brazil, it is necessary a broader engagement in developing studies and literacy programs for adults as political, educational and health goals. By raising the literacy levels, we expect to guarantee the rights of marginalized individuals in Brazilian society.

  • Open Access

    Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians

    by Vitor Santos de Souza, Sofia Brunchport Guazzelli, Leonardo Cardoso Cruz, Elisa de Paula França Resende, Leonardo Cruz de Souza, Maira Tonidandel Barbosa, Paulo Caramelli

    Background: The diagnosis of Alzheimer's disease (AD) can bring financial and emotional consequences to patients and caregivers. Whether or not the diagnosis should be disclosed to patients is a matter of debate amongst physicians and can be influenced by culture and experience. Objective: To investigate the current practice of physicians who attend and treat patients with dementia in Brazil regarding the disclosure of dementia diagnosis and compare the practice with what has been performed 15 years ago in the country. Methods: Data were evaluated using an electronic questionnaire. The questions used to carry out this research were similar to the questions of the study carried out 15 years ago 9. The form was sent to the Brazilian Academy of Neurology, the Brazilian Association of Geriatrics and Gerontology, and the Brazilian Association of Psychiatry, which forwarded it to their members. Analyses were conducted through non-parametric statistical tests, with a post-hoc assessment. Results: 397 physicians responded to the survey, of which 231 are neurologists, 124 geriatricians, 29 psychiatrists and 13 from other specialties. The mean age was 45.2 years. The majority (66.7%) of the physicians reveal the diagnosis of AD always or usually. The youngest group of neurologists were more likely to disclose the diagnosis than the oldest group with a significant difference between them. In comparison to the 2008 Brazilian study, the percentage of physicians who always or usually disclose the diagnosis has risen by 22%. On the other hand, 12.3% of the physicians rarely or never disclose the diagnosis, in comparison to 25,3% in 2008. The main reasons for not disclosing the diagnosis concern the patients' mental health. Conclusion: Advances in dementia knowledge and biomarkers availability probably explain the increase in the rate of disclosure. The main challenge is to reconcile the autonomy of affected individuals, mental health issues after the diagnosis and the family member's opinion.


  • Open Access

    High performance older adults in a population-based sample with low education: Pietà study

    by Karoline Carvalho Carmona, Elisa de Paula França Resende, Henrique Cerqueira Guimarães, Thais Helena Machado, Viviane Amaral-Carvalho, Etelvina Lucas dos Santos, Maira Tonidandel Barbosa, Paulo Caramelli

    Background Healthy brain aging can be defined as aging without neurological or psychiatric disorders, sustaining functional independence. In addition to the absence of disease and preserved functionality, there are individuals who stand out for their superior performance to that considered normal for their age in cognitive tests. These individuals are called “high-performance older adults” (HPOA). Objectives To investigate the presence of HPOA in an oldest-old population with low education, and if present, to investigate associations with sociodemographic, clinical, and lifestyle variables. Methods We evaluated 132 cognitively healthy individuals from the Pietà Study, a population-based investigation with 639 participants. We used the delayed recall from the Rey Auditory-Verbal Learning Test to verify the existence of HPOA and to classify participants based on their performance. Sociodemographic, clinical, and lifestyle variables associated with HPOA were investigated. Results We identified 18 individuals fulfilling HPOA criteria (age: 77.4 ± 2.6 years old; 14 women; education: 4.6 ± 3.4 years). The other participants, 114 total (age: 79.8 ± 4.5 years old; 69 women; education: 3.0 ± 2.7 years) were classified as “standard performance older adults” (SPOA). In multivariate analysis, younger age (odds ratio [OR] = 0.672; 95% confidence interval [CI]: 0.462–0.979; p = 0.037) and lower scores on the Geriatric Depression Scale (OR = 0.831; 95%CI: 0.688–0.989; p = 0.038) were associated with HPOA. Conclusions The present study identifies for the first time HPOA with low educational level, thereby reinforcing the existence of biological substrates related to this condition. Furthermore, the data suggest an association between younger age and less depressive symptoms with HPOA.